AstraZeneca still waiting for FDA decision to resume US trial

The US trial of AstraZeneca’s COVID-19 vaccine candidate remains on hold while regulators investigate an illness in one of the participants. (File/AFP)
Short Url
Updated 24 September 2020

AstraZeneca still waiting for FDA decision to resume US trial

  • AstraZeneca’s COVID-19 vaccine was initially developed by the University of Oxford

FRANKFURT: AstraZeneca is still waiting for the go-ahead from the US drug regulator to restart the clinical trial of its potential COVID-19 vaccine in the United States, Chief Executive Pascal Soriot said on Thursday.
“We are the sponsor of the US study. We then provided all this information to the FDA (US Federal Drug Administration) and we are waiting to hear their decision,” Soriot told a virtual World Economic Forum discussion.
The US trial of AstraZeneca’s COVID-19 vaccine candidate, initially developed by the University of Oxford, remains on hold while regulators investigate an illness in one of the participants, even after a British study and other programs outside of the United States have resumed.
US Health and Human Services Secretary Alex Azar said on Wednesday the continued suspension showed the FDA took vaccine safety seriously.
A document posted online by Oxford university last week stated the illness in a British participant that triggered the pause on Sept. 6 may not have been associated with the vaccine.


Russia’s coronavirus death toll passes 25,000

Updated 22 October 2020

Russia’s coronavirus death toll passes 25,000

  • Authorities reported 15,971 new coronavirus infections in the previous 24 hours
MOSCOW: Russia recorded 290 deaths from COVID-19 on Thursday, bringing its official death toll to 25,242.
Authorities reported 15,971 new coronavirus infections in the previous 24 hours, bringing the nationwide total to 1,463,306, the fourth highest in the world.